Cargando…
Does Testosterone Replacement Therapy Promote an Augmented Risk of Thrombotic Events in Thalassemia Major Male Patients with Hypogonadism?
Autores principales: | De Sanctis, Vincenzo, Daar, Shahina, Soliman, Ashraf T., Elsedfy, Heba, Khater, Doaa, Di Maio, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477457/ https://www.ncbi.nlm.nih.gov/pubmed/28670553 http://dx.doi.org/10.4103/ijem.IJEM_73_17 |
Ejemplares similares
-
Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018) -
Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men
por: Vincenzo, De Sanctis, et al.
Publicado: (2019) -
Current practice in treating adult female thalassemia major patients with hypogonadism: An International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine survey from Italy
por: De Sanctis, Vincenzo, et al.
Publicado: (2016) -
The experience of a tertiary unit on the clinical phenotype and management of hypogonadism in female adolescents and young adults with transfusion dependent thalassemia
por: Vincenzo, De Sanctis, et al.
Publicado: (2019) -
Late-onset Male Hypogonadism and Fertility Potential in Thalassemia Major Patients: Two Emerging Issues
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)